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Abstract 
Background: It is not established beyond doubt whether improvements in functional outcome after total knee 
arthroplasty (TKA) are maintained in the long term. We therefore investigated the temporal patterns of functional 
outcome [using range of motion (ROM), American Knee Society (AKS) score, Western Ontario and McMaster Universi-
ties Arthritis Index (WOMAC) score, and 36-Item Short Form Health Survey (SF-36) score] over a 5-year period after 
uncomplicated TKA, and whether these patterns differed by implant type and patient age.
Materials and methods: This prospective study evaluated 138 patients who underwent unilateral TKA with either a 
mobile-bearing (MB) or fixed-bearing (FB) posterior-stabilized prosthesis. An independent investigator evaluated the 
functional outcome at five time points: preoperatively and at 6-month, 1-year, 2-year, and 5-year follow-up. Differ-
ences in functional outcomes between adjacent time points were evaluated by mixed-effect model repeat measure-
ment (MMRM).
Results: The different functional outcome scores showed improvement till 6 months–2 years, followed by a variable 
decline. In patients aged ≥ 68 years with an MB implant, most of the functional outcome scores declined between 2 
and 5 years after variable initial improvement till 6 months–2 years, whereas the parameters plateaued after 2 years in 
those aged < 68 years and in older patients with an FB implant.
Conclusions: A decline in function and pain relief occurs 2 years after TKA. This decline is more evident in older 
patients with an MB prosthesis. Based on these findings, we believe that use of MB implants in older patients 
(≥ 68 years) requires further investigation.
Level of evidence: Level 3.
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Introduction
Evidence-based knowledge about the temporal pattern of 
functional results after total knee arthroplasty (TKA) has 
far-reaching clinical implications. Long-term follow-up 
studies after TKA have shown survival rates of up to 97% 
at 15 and 20  years [1, 2]. Survival rates provide impor-
tant information to physicians and patients; however, 
it is equally important to know how well the knee will 
function after TKA, in both the short and long term [3]. 
From the surgeon’s perspective, knowing the timeline of 
the extent of recovery and its maintenance after unevent-
ful TKA is important to counsel patients.
Literature provides contradicting information about 
the temporal pattern of improvement in functional out-
come after TKA. Over the last three decades, during 
which TKA has been successfully performed and evolved, 
only a handful of studies have attempted to address this 
issue [3–13]. Most previous studies are limited by the 
fact that either only the clinician-examined Knee Soci-
ety Score (KSS) was used for evaluation [4, 6, 7, 9] rather 
than patient-reported outcomes measures (PROMs), 
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which are of real value to the patient, or the time points 
at which the patients were assessed were too spaced out, 
thereby potentially missing the true timeline [5, 8, 12], or 
the number of patients available at final follow-up was 
too small [11], raising concerns about whether the find-
ings are generally applicable to society. While some stud-
ies suggest that pain and function continue to improve 
for 4–7 years after TKA [5, 12], others suggest that these 
improvements are limited to 2  years after TKA, after 
which they begin to decline [3, 8]. Although no evidence 
of the superiority of either fixed-bearing (FB) or mobile-
bearing (MB) types of implant has been found with 
respect to range of movement (ROM), pain, stiffness, or 
function [14], the rate of recovery may differ according to 
bearing type [15]. Furthermore, TKA performed at older 
patient age may affect the timeline of functional recovery, 
given the fact that such patients have a higher medical 
complication rate. Considering that we had prospectively 
collected data of a sizable number of patients at multiple 
time points by using various outcome scores up to mid-
term follow-up of 5 years, with both FB and MB types of 
implant, we believed that we were in a position to address 
these issues.
The aims of this study are: (1) to investigate the tempo-
ral patterns of functional outcomes [using ROM, Ameri-
can Knee Society Score [AKS], Western Ontario and 
McMaster Universities Arthritis Index (WOMAC) score, 
and 36-Item Short Form Health Survey (SF-36) score] 
over a 5-year period after uncomplicated TKA, and (2) 
to determine whether the temporal patterns of functional 




All patients who underwent primary TKA at our ter-
tiary care institution from November 2004 to May 2005 
were prospectively evaluated for functional outcome 
at five time points from preoperative assessment until 
5-year follow-up. This study was approved by the insti-
tutional review board of our hospital, and informed con-
sent for use of medical information was obtained from all 
patients.
Participants/study subjects
Patients with osteoarthritis (OA) who underwent uni-
lateral TKA during the study period and for whom out-
come data were available at each of the five time points 
were included for analysis. During the study period, 177 
patients underwent unilateral TKA at our institution and 
were assessed for eligibility. We excluded 23 patients on 
the basis of exclusion criteria and 8 patients on the basis 
of complications (Fig.  1). Moreover, complete follow-up 
data were not available for eight patients. Thus, 138 
patients had complete 5-year follow-up data and were 
thus included in the analysis. Of the patients, 131 were 
female (94.9%) and 7 were male (5.1%), with mean [stand-
ard deviation (SD)] age of 67.7 (5.6) years. Their mean 
(SD) body weight, height, and body mass index were 62.6 
(7.8) kg, 152.2 (6.0) cm, and 26.9 (3.0) kg/m2, respectively.
Surgical protocol
All TKAs were performed by a single surgeon using 
standard medial parapatellar arthrotomy with a tour-
niquet. One of two posteriorly stabilized prostheses 
[Genesis II (FB), Smith and Nephew, Memphis, USA or 
e.motion (MB), B. Braun Aesculap, Tuttlingen, Germany] 
was implanted for each patient. Implant selection was at 
surgeon discretion, without any preset selection criteria. 
For all cases, patellar resurfacing and cement fixation 
were performed. A standard postoperative rehabilitation 
protocol was used in all patients.
Outcome measures
Patients were evaluated by the same observer (one of the 
authors) at five time points, viz. preoperatively and at 
6-month, 1-year, 2-year, and 5-year postoperative follow-
up, by using ROM, AKS [16], WOMAC score [17], and 
SF-36 [18] score. The ROM of all patients was measured 
to the nearest 5° using a standard 38-cm clinical goni-
ometer with the patient in supine position, calculated 
by subtracting the flexion contracture from maximum 
flexion.
Statistical analysis
All statistical analyses were conducted by using SPSS ver-
sion 21.0 for Windows (SPSS Inc., Chicago, IL); p value 
< 0.05 was considered significant. Quantitative variables 
are expressed as mean and SD. Differences in functional 
outcome between adjacent time points were evaluated 
by mixed-effect model repeat measurement (MMRM). 
To determine whether temporal patterns of functional 
outcomes after TKA differed by implant type and patient 
age, we created four groups of patients as follows: (1) 
patients aged < 68 years with an FB implant (n = 31), (2) 
patients aged < 68 years with an MB implant (n = 32), (3) 
patients aged ≥ 68 years with an FB implant (n = 38), and 
(4) patients aged ≥ 68 years with an MB implant (n = 37). 
The number of patients aged < 68 and ≥ 68  years was 
63 and 75, respectively. Sixty-nine patients had an FB 
implant, while another 69 patients had an MB implant. 
The baseline demographic data of the two age groups 
and the two implant groups of patients were comparable 
(Tables 1 and 2). In the four groups, the functional out-
come scores between adjacent time points were com-
pared by MMRM. In comparing the functional outcomes, 
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we considered a difference of 5° in ROM and 6% in the 
outcome scales to be clinically important, as the motion 
arc was measured to the nearest 5° and a 6% difference in 
maximum score has been suggested as the minimal clini-









Excluded based on exclusion criteria
(n = 23)
Indication other than primary OA••••
•••••
Any hip or spineproblem
Serere OA in the other knee








Excluded based on missing data (n = 8)
Excluded based on complications
(n = 8)
Fig. 1 Flowchart showing details of patient enrollment and follow-up
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Results
The different functional outcome scores showed 
improvement up to 6 months–2 years, after which most 
of the parameters declined (Table  3). Before operation, 
the mean flexion contracture was 12° with further flex-
ion of up to 139° (ROM, 127.2°). The mean ROM showed 
improvement at 6 months (133.8°) and was constant after 
that till 1 year (134.2°), before demonstrating a decline at 
2 years (133.2°) and 5 years (130.2°), although the decline 
was not clinically important (Fig.  2a). The mean AKS 
knee score showed improvement at 6  months, a small 
decline at 1  year, then improvement again at 2  years, 
reaching the 6-month level. However, it again demon-
strated a decline between 2 and 5  years (Fig.  2b). The 
mean AKS functional score continuously improved until 
2 years and was then constant until 5 years (Fig. 2c). The 
mean WOMAC pain score showed a significant improve-
ment in pain until 1 year, a plateau until 2 years, then a 
marked decline between 2 and 5  years (Fig.  2d). The 
mean WOMAC stiffness score improved until 1  year 
then demonstrated a plateau phase until 5 years (Fig. 2e). 
The mean WOMAC function score showed improve-
ment until 1  year and was then constant until 2  years, 
before declining between 2 and 5  years (Fig.  2f ). The 
mean SF-36 physical component summary (PCS) score 
improved from baseline until 1  year and was constant 
until 2 years, before showing a decline at 5 years (Fig. 2g). 
The mean SF-36 mental component summary (MCS) 
score improved from baseline at 6 months, was constant 
until 2  years, then showed a marked decline between 2 
and 5 years (Fig. 2h). 
Most of the functional outcome scores declined 
between 2 and 5 years in patients aged ≥ 68 years with 
an MB implant, after a variable initial improvement for 
6  months to 2  years, whereas most of the parameters 
plateaued after 2 years in those aged < 68 years and in 
the older patients with an FB implant. In patients aged 
< 68  years with an FB implant, the AKS knee score, 
WOMAC pain score, WOMAC stiffness score, and 
WOMAC function score improved at 6  months and 
were constant thereafter until 5 years, whereas the AKS 
function score and SF-36 PCS showed improvement 
Table 1 Demographic data of  patients in  the  two age 
groups
Data presented as mean (SD) unless otherwise specified
BMI body mass index
Variable < 68 years old 
(n = 63)
≥ 68 years old 
(n = 75)
p-Value
Sex (female) 61 (96.8%) 70 (93.3%)
Age (years) 62.8 (3.8) 71.7 (3.2) < 0.001
Height (cm) 153.3 (5.4) 151.3 (6.4) 0.063
Weight (kg) 63.5 (6.7) 61.8 (8.7) 0.210
BMI (kg/m2) 26.9 (2.8) 27.0 (3.2) 0.911
Table 2 Demographic data of  patients in  the  two implant 
groups
Data presented as mean (SD) unless otherwise specified
MB mobile bearing, FB fixed bearing, BMI body mass index
MB (n = 69) FB (n = 69) p-Value
Sex (female) 64 (92.8%) 67 (97.1%)
Age (years) 66.8 (4.8) 68.5 (6.2) 0.069
Height (cm) 152.3 (6.4) 152.1 (5.7) 0.831
Weight (kg) 62.4 (7.8) 62.7 (7.9) 0.802
BMI (kg/m2) 26.9 (2.9) 27.0 (3.1) 0.866
Table 3 Temporal patterns of functional outcome scales during the 5-year period
Preop. preoperative, PO postoperative, ROM range of movement, AKS American Knee Society score, WOMAC Western Ontario and McMaster Universities Arthritis Index 
score, SF-36 36-Item Short Form Health Survey, PCS physical component summary, MCS mental component summary
Italics indicates significant p-values
Score Preop. p-Value PO 6 months p-Value PO 1 year p-Value PO 2 years p-Value PO 5 years
ROM 127.2 (1.4) < 0.001 133.8 (0.7) 0.436 134.2 (0.8) 0.043 133.2 (1.0) < 0.001 130.2 (1.0)
AKS
 Knee score (100) 44.4 (0.7) < 0.001 95.2 (0.5) 0.001 93.5 (0.5) 0.001 95.0 (0.5) < 0.001 92.5 (0.6)
 Function score (100) 58.7 (1.0) < 0.001 91.3 (0.9) < 0.001 96.3 (0.8) 0.040 97.7 (0.6) 0.186 96.4 (0.9)
WOMAC
 Pain (20) 11.4 (0.3) < 0.001 3.0 (0.3) 0.012 2.2 (0.2) 0.329 1.9 (0.3) 0.002 3.2 (0.4)
 Stiffness (8) 4.8 (0.2) < 0.001 2.3 (0.1) < 0.001 1.7 (0.1) 0.192 1.5 (0.1) 0.166 1.8 (0.2)
 Function (68) 39.5 (1.0) < 0.001 18.7 (0.9) < 0.001 14.4 (0.8) 0.242 13.5 (0.8) 0.002 17.7 (1.3)
SF-36
 PCS 29.3 (0.5) < 0.001 41.3 (0.7) < 0.001 45.4 (0.6) 0.356 44.6 (0.7) 0.002 42.0 (0.8)
 MCS 42.0 (1.0) 0.001 46.8 (1.0) 0.086 48.9 (0.9) 0.854 49.1 (1.0) 0.002 44.8 (1.2)
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Fig. 2 Line diagrams depicting the various outcome parameters over 5 years (error bars depict standard deviation): a ROM, b AKS knee score, c AKS 
function score; d WOMAC pain score, e WOMAC stiffness score, f WOMAC function score, g SF-36 PCS score, and h SF-36 MCS score
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until 1  year before becoming constant up to 5  years 
(Table  4). The SF-36 MCS score tended to improve at 
6 months (p = 0.062), after which it showed a constant 
value until 5  years. ROM did not show any improve-
ment from baseline until 5  years. In the patients aged 
< 68  years with an MB implant, the ROM, AKS knee 
score, WOMAC stiffness score, and SF-36 MCS score 
improved at 6 months, whereas the AKS function score 
improved until 2  years and the WOMAC pain score, 
WOMAC function score, and SF-36 MCS showed 
improvement until 1  year. Except for ROM, which 
declined, and the WOMAC function score, which 
showed a tendency to decline (p = 0.092), all other 
scores were constant between 2 and 5 years (Table 5). In 
patients aged ≥ 68 years with an FB implant, ROM and 
AKS function scores improved at 6 months, whereas the 
WOMAC stiffness score improved until 1 year, and the 
AKS knee score, WOMAC pain score, WOMAC func-
tion score, and SF-36 PCS showed improvement until 
2  years. The SF-36 MCS score, on the other hand, did 
not show any improvement from baseline until 5 years. 
The ROM and SF-36 PCS score declined, and the AKS 
knee score (p = 0.082) and WOMAC function score 
(p = 0.088) showed a tendency to decline between 2 and 
5  years (Table  6). In patients aged ≥ 68  years with an 
MB implant, the ROM, AKS knee score, WOMAC pain 
score, and SF-36 MCS score improved at 6  months, 
whereas the AKS function score, WOMAC function 
score, and SF-36 PCS score improved until 1 year, and 
the WOMAC stiffness score improved until 2 years. All 
Table 4 Temporal pattern of functional outcome scales in patients aged < 68 years with an FB implant
FB fixed bearing, Preop. preoperative, PO postoperative, ROM range of movement, AKS American Knee Society score, WOMAC Western Ontario and McMaster 
Universities Arthritis Index score, SF-36 36-Item Short Form Health Survey, PCS physical component summary, MCS mental component summary
Italics indicates significant p-values
Score Preop. p-Value PO 6 months p-Value PO 1 year p-Value PO 2 years p-Value PO 5 years
ROM 134.2 (2.1) 0.603 135.5 (1.9) 0.231 133.9 (2.5) 0.547 134.5 (2.8) 0.071 132.9 (2.5)
AKS
 Knee score (100) 48.1 (1.2) < 0.001 95.8 (0.9) 0.209 94.6 (1.2) 0.615 95.1 (1.1) 0.069 92.1 (1.7)
 Function score (100) 58.6 (2.2) < 0.001 92.9 (1.7) < 0.001 99.3 (0.5) 0.758 99.0 (0.9) 0.891 99.1 (0.9)
WOMAC
 Pain (20) 12.3 (0.7) < 0.001 2.5 (0.5) 0.212 1.6 (0.5) 0.852 1.5 (0.4) 0.336 2.3 (0.7)
 Stiffness (8) 4.8 (0.4) < 0.001 2.0 (0.3) 0.122 1.4 (0.2) 0.653 1.6 (0.2) 0.916 1.6 (0.4)
 Function (68) 39.6 (2.3) < 0.001 13.4 (1.9) 0.342 11.9 (1.7) 0.780 11.5 (1.4) 0.673 12.6 (2.6)
SF-36
 PCS 31.2 (1.0) < 0.001 44.6 (1.7) 0.048 48.1 (1.1) 0.436 46.8 (1.3) 0.272 44.5 (1.9)
 MCS 39.8 (2.4) 0.062 45.7 (2.6) 0.484 48.2 (1.9) 0.798 49.0 (2.2) 0.152 44.1 (2.2)
Table 5 Temporal pattern of functional outcome scales in patients aged < 68 years with an MB implant
MB mobile bearing, Preop. preoperative, PO postoperative, ROM range of movement, AKS American Knee Society score, WOMAC Western Ontario and McMaster 
Universities Arthritis Index score, SF-36 36-Item Short Form Health Survey, PCS physical component summary, MCS mental component summary
Italics indicates significant p-values
Score Preop. p-Value PO 6 months p-Value PO 1 year p-Value PO 2 years p-Value PO 5 years
ROM 127.0 (2.9) 0.022 133.3 (1.2) 0.198 134.4 (1.3) 0.017 132.2 (1.5) 0.001 128.3 (1.6)
AKS
 Knee score (100) 44.1 (1.9) < 0.001 94.6 (1.2) 0.003 91.2 (1.2) 0.006 93.7 (0.9) 0.671 93.4 (1.1)
 Function score (100) 59.7 (2.7) < 0.001 95.0 (1.8) 0.722 95.6 (1.6) 0.022 98.1 (1.1) 0.521 98.1 (1.1)
WOMAC
 Pain (20) 10.6 (0.9) < 0.001 3.9 (0.7) 0.014 2.4 (0.4) 0.806 2.3 (0.4) 0.718 2.1 (0.5)
 Stiffness (8) 4.6 (0.4) < 0.001 2.4 (0.3) 0.121 2.0 (0.3) 0.589 1.8 (0.2) 0.171 1.3 (0.2)
 Function (68) 38.2 (2.6) < 0.001 22.4 (2.0) < 0.001 13.4 (1.2) 0.231 15.4 (1.4) 0.092 11.4 (2.1)
SF-36
 PCS 29.2 (1.3) < 0.001 39.9 (1.6) 0.001 46.6 (1.2) 0.023 43.2 (1.3) 0.279 45.3 (1.2)
 MCS 41.8 (1.5) 0.002 47.0 (1.9) 0.340 48.9 (1.5) 0.314 46.8 (1.8) 0.193 50.3 (1.8)
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scores except the AKS function score declined between 
2 and 5 years (Table 7).
Discussion
Literature provides contradicting information regard-
ing the temporal pattern of improvement in functional 
outcome after TKA. This uncertainty is further com-
pounded by the fact that different outcome measure-
ment tools are known to produce different results and 
have different capabilities [20]. Using generic, disease-
specific, and performance-based measurements is there-
fore recommended to fully appreciate recovery after 
knee replacement [20, 21]. We prospectively evaluated 
functional outcome after uncomplicated TKA at various 
time points over 5  years using three different outcome 
measures, encompassing clinician- and patient-reported 
tools, besides ROM. We also identified differences, if 
any, in functional outcome after TKA over the same time 
points between FB and MB prostheses, and between 
patients aged ≥ 68 years as compared with their younger 
counterparts.
We found that most of the functional outcome param-
eters improved for 6  months to 2  years, followed by a 
downward trend between 2 and 5 years after uncompli-
cated TKA. Some previous studies have suggested that 
pain and function continue to improve for 4–7 years after 
TKA [5, 12]. A prospective study evaluating 49 total hip 
arthroplasty (THA)/TKA patients found a significant 
improvement in the WOMAC score and some compo-
nents of the SF-36 score between 6 months and 7 years 
[5]. However, those authors did not study the outcome 
parameters between 6  months and 7  years, and this 
Table 6 Temporal pattern of functional outcome scales in patients aged ≥ 68 years with an FB implant
FB fixed bearing, Preop. preoperative, PO postoperative, ROM range of movement, AKS American Knee Society score, WOMAC Western Ontario and McMaster 
Universities Arthritis Index score, SF-36 36-Item Short Form Health Survey, PCS physical component summary, MCS mental component summary
Italics indicates significant p-values
Score Preop. p-Value PO 6 months p-Value PO 1 year p-Value PO 2 years p-Value PO 5 years
ROM 122.6 (2.6) 0.001 133.0 (1.3) 0.313 134.0 (1.3) 0.022 132.0 (1.3) < 0.001 127.5 (1.8)
AKS
 Knee score (100) 43.6 (1.2) < 0.001 94.7 (0.9) 0.708 94.3 (0.8) 0.010 96.7 (0.6) 0.082 94.9 (0.8)
 Function score (100) 59.2 (1.7) < 0.001 88.7 (1.7) 0.173 91.6 (2.1) 0.517 93.0 (1.6) 0.367 95.3 (1.7)
WOMAC
 Pain (20) 11.2 (0.5) < 0.001 2.9 (0.5) 0.420 3.3 (0.5) 0.015 2.0 (0.5) 0.177 3.4 (0.8)
 Stiffness (8) 4.8 (0.3) < 0.001 2.4 (0.2) 0.014 1.6 (0.2) 0.842 1.6 (0.2) 0.484 1.9 (0.4)
 Function (68) 40.6 (1.8) < 0.001 19.9 (1.6) 0.968 19.9 (1.7) 0.013 16.2 (1.5) 0.088 21.3 (2.9)
SF-36
 PCS 27.5 (0.7) < 0.001 39.2 (1.2) 0.043 41.8 (1.1) 0.027 45.1 (1.4) 0.001 36.5 (2.2)
 MCS 45.5 (1.9) 0.652 46.5 (1.9) 0.855 46.9 (1.9) 0.874 47.1 (2.0) 0.171 43.2 (2.6)
Table 7 Temporal pattern of functional outcome scales in patients aged ≥ 68 years with an MB implant
MB mobile bearing, Preop. preoperative, PO postoperative, ROM range of movement, AKS American Knee Society score, WOMAC Western Ontario and McMaster 
Universities Arthritis Index score, SF-36 36-Item Short Form Health Survey, PCS physical component summary, MCS mental component summary
Italics indicates significant p-values
Score Preop. p-Value PO 6 months p-Value PO 1 year p-Value PO 2 years p-Value PO 5 years
ROM 126.2 (2.8) 0.003 133.5 0.362 134.3 (1.6) 0.900 134.2 (1.9) 0.027 132.0 (2.2)
AKS
 Knee score (100) 42.5 (1.3) < 0.001 95.8 (1.1) 0.052 93.9 (1.0) 0.852 94.0 (1.1) < 0.001 90.1 (1.2)
 Function score (100) 57.6 (2.4) < 0.001 89.5 (2.0) < 0.001 98.9 (0.8) 0.944 98.8 (0.8) 0.837 95.2 (2.4)
WOMAC
 Pain (20) 11.4 (0.6) < 0.001 2.6 (0.5) 0.069 1.5 (0.3) 0.297 2.2 (0.6) < 0.001 4.3 (0.8)
 Stiffness (8) 5.0 (0.3) < 0.001 2.4 (0.2) 0.013 1.8 (0.2) 0.035 1.2 (0.2) 0.001 2.3 (0.3)
 Function (68) 39.1 (1.6) < 0.001 18.6 (1.3) < 0.001 12.4 (1.3) 0.612 11.6 (1.4) < 0.001 21.0 (2.0)
SF-36
 PCS 29.5 (0.8) < 0.001 42.0 (1.4) 0.013 45.8 (1.4) 0.442 44.7 (1.3) 0.016 40.7 (1.2)
 MCS 40.6 (1.8) 0.003 47.7 (1.9) 0.126 51.4 (1.6) 0.427 52.6 (1.5) < 0.001 43.4 (2.0)
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large gap in the timeline may mask important trends in 
the results, which could have important clinical impli-
cations. In our study, we evaluated the parameters at 
relatively short time intervals to address this limitation. 
Another study, evaluating perceived physical function-
ing in 44 THA/TKA patients by using the Hip Disabil-
ity and Osteoarthritis Outcome Score (HOOS) and the 
Knee Injury and Osteoarthritis Outcome Score (KOOS) 
questionnaires, found a more significant improvement at 
4 years than at 6 months [12]. However, no objective and 
clinician-reported outcome measures were used in that 
study. Moreover, the sample size was too small to make 
any definite conclusions, and the outcome was evaluated 
at fewer time points. We assessed functional outcome by 
using various outcome measurement tools, encompass-
ing clinician- and patient-reported scores.
A few studies in literature suggest that improvements 
in functional parameters are limited to 1–2  years after 
TKA, after which they begin to decline [3, 8]. A pro-
spective study, evaluating health-related quality of life 
(HRQOL) in 102 consecutive TKA patients by using 
the KOOS and SF-36 scores, found that the maximum 
improvement was evident at 1 year, after which the scores 
declined until 5 years [8]. However, that was a question-
naire-based study and did not consider objective clini-
cal parameters. In our study, which assessed functional 
outcome using objective parameters, we also observed a 
decline in most scores between 2 and 5  years. Another 
study, evaluating functional results in 50 TKA patients 
by using KOOS and ROM measurements, reported that 
most of the improvements in pain and function were 
achieved by 6 months, with further small improvements 
up to 2  years before a small decline at 4  years [3]. Our 
findings closely resemble those of previous studies, while 
assessing function more elaborately and incorporating 
more patients. Although painful patellar clunk or crepi-
tation (PCC) has been reported as one of the causes for 
late-onset pain after TKA, especially with contemporary 
posterior-stabilized prosthesis designs, no patients with 
an e.motion implant and only one patient with a Gene-
sis II were diagnosed with PCC in a retrospective study 
of 948 primary posterior-stabilized TKAs [22]. Further-
more, the implant design of the two prostheses, includ-
ing the shapes of the patellar component and trochlear 
groove, have not been specifically reported to be linked 
with knee pain or decreased ROM after TKA, thus rul-
ing out implant-related bias in the decline of functional 
scores observed in this study.
We observed that the temporal pattern of functional 
outcome after TKA differed according to both implant 
type and patient age. Previously published studies on 
the effect of implant type (FB or MB) on the evolution of 
functional outcome after TKA could not find any such 
differences between the two implant groups [14, 23]. 
The theoretical advantage of MB TKA designs, due to 
increased congruity and unconstrained mobility of the 
bearing, has not been translated into improved long-term 
clinical outcomes or implant survivorship. A meta-anal-
ysis of the two TKA designs did not find any significant 
difference in clinical or radiological outcomes and com-
plication rates between fixed- and mobile-bearing TKAs 
[14]. However, the above-mentioned study did not con-
sider various time points in the recovery after TKA, 
which has important clinical implications. In our study, 
we evaluated the functional outcome after TKA in the 
two groups at various time points, to comprehensively 
evaluate patterns of recovery. A randomized controlled 
clinical trial comparing the outcomes of FB and MB 
TKAs found that most of the gait parameters improved 
at 5 years after TKAs using FB implants in older patients 
(> 70 years) and for TKAs using MB implants in younger 
patients [15]. However, their sample size was relatively 
small; moreover, they did not comprehensively study 
the temporal pattern of recovery in the various sub-
groups. We used MMRM to study the pattern of recov-
ery in functional outcome at various time points, which 
has been reported to be a superior approach for con-
trolling type  I error rates and minimizing biases [24]. 
MB TKA designs have evolved over time, based on the 
range of freedom of the polyethylene insert, from the ini-
tial meniscal design to the rotating platform type, finally 
leading to the development of the anteroposterior glide 
platform variety. However, in a retrospective comparative 
study of the three types of mobile bearings, no difference 
in clinical or radiological results or implant survivorship 
was reported [25].
Only limited information is available in literature 
regarding comparison of the temporal pattern of func-
tional outcome after TKA in older versus young patients. 
A prospective study comparing functional outcome and 
pain after TKA between patients aged ≤ 55  years and 
> 55  years at time of index surgery found no significant 
difference in pain or knee performance over 10 years of 
follow-up between the two groups. The authors, how-
ever, found higher overall function in the younger age 
group throughout the study period [26]. However, they 
did not evaluate the temporal pattern of recovery in the 
two groups at various time points. In our study, which 
had a relatively larger sample size, we found a decline 
in function between 2 and 5  years in the older patients 
(≥ 68  years) when implanted with an MB prosthesis. 
Considering the greater degree of freedom of movement 
provided by an MB implant compared with a fixed-bear-
ing one, full function of the former implant appears to be 
more dependent on adequate quadriceps muscle power. 
The decline in functional outcome seen in older patients 
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with an MB implant may be explained by decreased mus-
cle strength associated with aging in such patients.
This study has a number of strengths, including use 
of a standardized clinical pathway, use of validated out-
come measures, and 5-year follow-up. However, there are 
some limitations to this study, which should be consid-
ered when interpreting the results. First, we did not have 
a control group with which to compare the changes in 
functional outcome over the 5-year period. However, in 
an extensive literature review, we could not find any long-
term prospective study that evaluated such outcome 
measures in a healthy population. Therefore, the above 
results can be assumed to be relevant to the general pop-
ulation. Second, as we only included unilateral TKAs in 
our study, effects of OA of the other knee on the serial 
outcome measures cannot be ruled out. However, to 
reduce this ambiguity, we excluded patients with severe 
OA of the other knee from analysis in the study. Moreo-
ver, this study provides empirical data that lay the path 
for future studies on bilateral TKA. Third, the lack of ran-
domization regarding the type of prosthesis (FB or MB) 
used precludes the abolition of an inherent selection bias 
in the study. This should be borne in mind when inter-
preting the results. The use of a single type of FB or MB 
implant for all patients is another limitation that requires 
consideration, as this could be a potential source of selec-
tion bias.
In conclusion, a decline in function and pain relief 
occurs after 2 years following TKA. This decline is more 
evident in older patients (≥ 68  years) and in those with 
a MB prosthesis. Patients should be counseled preop-
eratively about the anticipated decline in function over 
time after 2  years following TKA. Based on these find-
ings, we believe that use of MB implants in older patients 
(≥ 68  years) should be questioned. We further recom-
mend future studies with larger sample size and longer 
follow-up to comprehensively evaluate the effect of MB 
implants in older patients.
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